Home » Industry, Regulators to Bolster Supply-Chain Standards
Industry, Regulators to Bolster Supply-Chain Standards
May 19, 2009
Manufacturers of generic and brand drugs can help protect the supply chain against economically motivated adulteration through industry consortiums such as Rx-360 and increased penalties for tampering, PhRMA says. The FDA held a public meeting to discuss how agency-regulated industries can recognize and prevent economically motivated adulteration such as contaminated heparin. PhRMA has recommended a few approaches, including measures that would be promoted by the consortium, Martin Van Trieste, chairman of the association’s quality technical group, said at the meeting.
Generic Line
Generic Line
Upcoming Events
-
21Oct